Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1823730

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1823730

In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030

PUBLISHED:
PAGES: 379 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The IVD quality controls market is valued at an estimated USD 1.65 billion in 2025 and is projected to reach USD 2.15 billion by 2030, at a CAGR of 5.5% during the forecast period.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD)
SegmentsProduct & Service, Technology, Manufacturer Type, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

IVD quality controls play a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results across clinical laboratories and healthcare facilities. The growing adoption of third-party quality controls is one of the major drivers of the IVD quality controls market. Unlike instrument-specific controls, third-party solutions offer greater flexibility, compatibility across multiple platforms, and longer shelf life.

In Vitro Diagnostics (IVD) Quality Control Market - IMG1

They provide unbiased performance assessment and consistent analyte stability, helping laboratories maintain reproducible and reliable results. With increasing regulatory and accreditation requirements, laboratories are favoring third-party controls to ensure compliance while optimizing workflow efficiency. The rising use of multianalyte controls further enhances demand, allowing simultaneous monitoring of multiple assays and reducing operational costs. Hospitals and clinical laboratories, in particular, are adopting these solutions to support high-volume testing and diverse diagnostic applications. This shift toward third-party quality controls continues to drive innovation, adoption, and sustained growth in the global IVD quality controls market.

"By product & service, the quality control products segment dominated the IVD quality controls market in 2024."

By product & service, the IVD quality controls market is segmented into quality control products, data management solutions, and quality assurance services. In 2024, quality control products held the largest share, driven by the increasing number of diagnostic tests and the need for accurate, reliable, and reproducible results. Regulatory and accreditation requirements further support their adoption, as laboratories aim to maintain compliance and ensure patient safety. Quality control products enable consistent performance monitoring across multiple assays and platforms, helping reduce errors and improve workflow efficiency. The rising use of third-party and multianalyte controls has further strengthened this segment, allowing simultaneous testing of multiple analytes while optimizing operational costs. Overall, QC products remain the backbone of laboratory quality management, making them the dominant segment within the IVD quality controls market.

"By manufacturer type, the third-party controls segment is projected to achieve the highest growth during the forecast period."

By manufacturer type, the IVD quality controls market is segmented into third-party controls and original equipment manufacturer (OEM) controls. Third-party controls are projected to be the fastest-growing segment during the forecast period. Their compatibility across multiple platforms, longer shelf life, and unbiased performance assessment make them increasingly preferred by laboratories. Third-party controls also support multianalyte testing and standardized QC procedures, helping laboratories improve workflow efficiency and ensure reproducible results. While OEM controls remain important for instrument-specific applications, the growing demand for versatile, cost-effective, and reliable solutions continues to drive the rapid adoption of third-party controls globally.

"The Asia Pacific is projected to be the fastest-growing regional market during the forecast period."

The market for IVD quality controls is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is anticipated to be the fastest-growing region in the IVD quality controls market during the forecast period, driven by the rapid development of healthcare infrastructure and increasing investment in advanced diagnostic technologies. The region is witnessing a growing number of clinical laboratories, hospitals, and diagnostic centers, which is boosting the demand for reliable and accurate quality control products. Rising awareness about the importance of early disease detection, coupled with regulatory initiatives to improve laboratory standards, is further supporting market growth. Additionally, the expanding patient population and the rising prevalence of chronic and infectious diseases are creating strong demand for quality control solutions to ensure accuracy and reproducibility.

Breakdown of the profiles of primary participants in the IVD quality controls market:

  • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%)
  • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

The key players in the IVD quality controls market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Randox Laboratories Ltd. (UK), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), Danaher Corporation (US), Sysmex Corporation (Japan), Bio-Techne Corporation (US), Microbix Biosystems Inc. (Canada), Microbiologics, Inc. (US), ZeptoMetrix (US), Fortress Diagnostics (UK), Helena Laboratories Corporation (US), Streck, Inc. (US), SERO AS (Norway), Maine Molecular Quality Controls, Inc. (US), Sun Diagnostics, LLC (US), Alpha-Tec (US), Grifols, S.A. (Spain), ConeBioproducts (US), Eurotrol B.V. (Netherlands), and Biorex Diagnostics (UK).

Research Coverage:

This research report categorizes the IVD quality controls market by product & service (quality control products, data management solutions, and quality assurance services), technology (immunoassays, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, and other technologies), manufacturer type [third-party controls ([independent controls, instrument-specific controls), original equipment manufacturer controls], end user (hospitals, clinical laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the IVD quality controls market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. A competitive analysis of upcoming startups in the IVD quality controls market ecosystem is covered in this report.

Reasons to Buy this Report:

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD quality controls market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, rising demand for external quality assessment support, rising geriatric population and subsequent growth in prevalence of chronic

and infectious diseases, and increasing adoption of PoC instruments in developed regions), opportunities (rising demand for multianalyte controls and increasing growth opportunities in emerging economies), restraints (additional costs and budget constraints in hospitals and laboratories and unfavorable reimbursement scenario for IVD tests), and challenges (stringent product approval process and lack of regulations for clinical laboratory accreditation in several emerging countries) influencing the growth of the IVD quality controls market.

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD quality controls market
  • Market Development: Comprehensive information about lucrative markets across varied regions
  • Market Diversification: Exhaustive information about products, untapped geographies, recent developments, and investments in the IVD quality controls market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), and F. Hoffmann-La Roche Ltd. (Switzerland)
Show more
Product Code: MD 4180

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
  • 1.4 INCLUSIONS & EXCLUSIONS
    • 1.4.1 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 KEY STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key secondary sources
      • 2.2.1.2 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 PARAMETRIC ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 IVD QUALITY CONTROLS MARKET OVERVIEW
  • 4.2 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030
  • 4.3 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2025 VS. 2030
  • 4.4 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2025 VS. 2030
  • 4.5 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030
  • 4.6 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of accredited clinical laboratories
      • 5.2.1.2 Growing adoption of third-party quality controls
      • 5.2.1.3 Rising demand for external quality assessment support
      • 5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases
      • 5.2.1.5 Increasing adoption of POC instruments in developed regions
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Additional costs and budget constraints in hospitals and laboratories
      • 5.2.2.2 Unfavorable reimbursement scenario for IVD tests
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising demand for multianalyte controls
      • 5.2.3.2 Increasing growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent product approval process
      • 5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, 2023-2025
    • 5.3.2 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023-2025
    • 5.3.3 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, BY REGION, 2023-2025
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA (HS CODE 3822)
    • 5.7.2 EXPORT DATA (HS CODE 3822)
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 IVD QUALITY CONTROLS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATORY FRAMEWORK
      • 5.10.1.1 North America
        • 5.10.1.1.1 US
        • 5.10.1.1.2 Canada
      • 5.10.1.2 Europe
        • 5.10.1.2.1 Germany
        • 5.10.1.2.2 UK
        • 5.10.1.2.3 France
        • 5.10.1.2.4 Italy
      • 5.10.1.3 Asia Pacific
        • 5.10.1.3.1 China
        • 5.10.1.3.2 Japan
        • 5.10.1.3.3 India
      • 5.10.1.4 Latin America
        • 5.10.1.4.1 Brazil
        • 5.10.1.4.2 Mexico
      • 5.10.1.5 Middle East
      • 5.10.1.6 Africa
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Immunoassays
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Molecular diagnostics
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Clinical chemistry
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: QUALITY CONTROL DATA MANAGEMENT WITH UNITY REAL-TIME IN MOLECULAR VIROLOGY
    • 5.16.2 CASE STUDY 2: ENHANCING RELIABILITY OF INFLUENZA DIAGNOSTICS WITH EXTERNAL QUALITY CONTROLS
  • 5.17 IMPACT OF AI/GENERATIVE AI ON IVD QUALITY CONTROLS MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL OF AI
    • 5.17.3 AI USE CASES
    • 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY AND USE CASE
    • 5.17.5 FUTURE OF AI IN IVD QUALITY CONTROLS MARKET
  • 5.18 IMPACT OF 2025 US TARIFFS ON IVD QUALITY CONTROLS MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 IMPACT ON COUNTRY/REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals
      • 5.18.5.2 Clinical laboratories
      • 5.18.5.3 Academic & research institutes

6 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 QUALITY CONTROL PRODUCTS
    • 6.2.1 SERUM/PLASMA-BASED CONTROLS
      • 6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls
    • 6.2.2 WHOLE BLOOD-BASED CONTROLS
      • 6.2.2.1 Rising need to ensure high-quality clinical test results to drive market
    • 6.2.3 URINE-BASED CONTROLS
      • 6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls
    • 6.2.4 OTHER CONTROLS
  • 6.3 DATA MANAGEMENT SOLUTIONS
    • 6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH
  • 6.4 QUALITY ASSURANCE SERVICES
    • 6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES

7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 IMMUNOASSAYS
    • 7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS
  • 7.3 CLINICAL CHEMISTRY
    • 7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH
  • 7.4 MOLECULAR DIAGNOSTICS
    • 7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS
  • 7.5 MICROBIOLOGY
    • 7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH
  • 7.6 HEMATOLOGY
    • 7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS
  • 7.7 COAGULATION & HEMOSTASIS
    • 7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION & HEMOSTASIS TESTING
  • 7.8 OTHER TECHNOLOGIES

8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE

  • 8.1 INTRODUCTION
  • 8.2 THIRD-PARTY CONTROLS
    • 8.2.1 INDEPENDENT CONTROLS
      • 8.2.1.1 Unbiased and independent performance assessment for analytical processes to drive adoption
    • 8.2.2 INSTRUMENT-SPECIFIC CONTROLS
      • 8.2.2.1 Dependence on instrument-specific compatibility to restrict demand
  • 8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS
    • 8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES

9 IVD QUALITY CONTROLS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET
  • 9.3 CLINICAL LABORATORIES
    • 9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH
  • 9.5 OTHER END USERS

10 IVD QUALITY CONTROLS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 High healthcare expenditure to propel market growth
    • 10.2.3 CANADA
      • 10.2.3.1 Government initiatives and research funding to support market growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Rising volume of high-quality tests performed to support market growth
    • 10.3.3 UK
      • 10.3.3.1 Growing number of diagnostic centers to drive market
    • 10.3.4 FRANCE
      • 10.3.4.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising incidence of chronic diseases to support market growth
    • 10.3.7 RUSSIA
      • 10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market
    • 10.3.8 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Growing access to modern healthcare and government support to boost market growth
    • 10.4.3 JAPAN
      • 10.4.3.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to dominate Latin American IVD quality controls market
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing number of accredited clinical laboratories to support market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 SAUDI ARABIA
      • 10.6.2.1 Rising government healthcare expenditure to boost market
    • 10.6.3 UAE
      • 10.6.3.1 Improvements in healthcare infrastructure to support growth
    • 10.6.4 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN IVD QUALITY CONTROLS MARKET
  • 11.3 REVENUE ANALYSIS, 2022-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product & service footprint
      • 11.5.5.4 Technology footprint
      • 11.5.5.5 Manufacturer type footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key emerging players/startups, by product & service and manufacturer type
      • 11.6.5.3 Competitive benchmarking of key startups/SMEs, by region
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
    • 11.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 BIO-RAD LABORATORIES, INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products & services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product & service launches
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products & services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 ABBOTT
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products & services offered
      • 12.1.3.3 MnM view
        • 12.1.3.3.1 Key strengths
        • 12.1.3.3.2 Strategic choices
        • 12.1.3.3.3 Weaknesses & competitive threats
    • 12.1.4 LGC LIMITED
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products & services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 F. HOFFMANN-LA ROCHE LTD.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products & services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 RANDOX LABORATORIES LTD.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products & services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product & service launches
        • 12.1.6.3.2 Deals
    • 12.1.7 SIEMENS HEALTHINEERS AG
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products & services offered
    • 12.1.8 QUIDELORTHO CORPORATION
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products & services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
        • 12.1.8.3.2 Expansions
    • 12.1.9 DANAHER CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products & services offered
    • 12.1.10 SYSMEX CORPORATION
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products & services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product & service launches
        • 12.1.10.3.2 Deals
        • 12.1.10.3.3 Expansions
    • 12.1.11 BIO-TECHNE CORPORATION
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products & services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product & service launches
        • 12.1.11.3.2 Deals
        • 12.1.11.3.3 Expansions
    • 12.1.12 MICROBIX BIOSYSTEMS INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products & services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product & service launches
        • 12.1.12.3.2 Deals
    • 12.1.13 GRIFOLS, S.A.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products & services offered
    • 12.1.14 MICROBIOLOGICS, INC.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products & services offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Deals
    • 12.1.15 ZEPTOMETRIX
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products & services offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product & service launches & approvals
    • 12.1.16 FORTRESS DIAGNOSTICS
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products & services offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 HELENA LABORATORIES CORPORATION
    • 12.2.2 STRECK, INC.
    • 12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC.
    • 12.2.4 SUN DIAGNOSTICS, LLC
    • 12.2.5 SERO AS
    • 12.2.6 CONEBIOPRODUCTS
    • 12.2.7 ALPHA-TEC
    • 12.2.8 EUROTROL B.V.
    • 12.2.9 BIOREX DIAGNOSTICS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Product Code: MD 4180

List of Tables

  • TABLE 1 IVD QUALITY CONTROLS MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 2 IVD QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 NUMBER OF CANCER PATIENTS WORLDWIDE, BY REGION, 2022 VS. 2035 VS. 2045
  • TABLE 4 AVERAGE SELLING PRICING TREND OF IVD QUALITY CONTROL PRODUCTS, 2023-2025 (USD)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023-2025 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, BY REGION, 2023-2025 (USD)
  • TABLE 7 LIST OF MAJOR PATENTS, 2023-2025
  • TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 9 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 10 IMPACT OF PORTER'S FORCES ON IVD QUALITY CONTROLS MARKET
  • TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
  • TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS
  • TABLE 14 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 15 CLASSIFICATION OF IVD DEVICES IN EUROPE
  • TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
  • TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 IVD QUALITY CONTROLS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE (%)
  • TABLE 25 KEY BUYING CRITERIA, BY PRODUCT & SERVICE
  • TABLE 26 RECIPROCAL TARIFF RATES ADJUSTED BY US
  • TABLE 27 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 28 KEY IVD QUALITY CONTROL PRODUCTS AVAILABLE IN MARKET
  • TABLE 29 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 30 IVD QUALITY CONTROL PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 37 SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 NORTH AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 EUROPE: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 LATIN AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 MIDDLE EAST & AFRICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 44 WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 EUROPE: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 LATIN AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 URINE-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 51 URINE-BASED QUALITY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 EUROPE: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 OTHER QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 58 OTHER QUALITY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 EUROPE: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 LATIN AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 MIDDLE EAST & AFRICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
  • TABLE 65 DATA MANAGEMENT SOLUTIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 EUROPE: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 LATIN AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 MIDDLE EAST & AFRICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS
  • TABLE 72 QUALITY ASSURANCE SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 EUROPE: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 LATIN AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 MIDDLE EAST & AFRICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 79 QUALITY CONTROLS FOR IMMUNOASSAYS AVAILABLE IN MARKET
  • TABLE 80 IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 QUALITY CONTROLS FOR CLINICAL CHEMISTRY AVAILABLE IN MARKET
  • TABLE 87 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS AVAILABLE IN MARKET
  • TABLE 94 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 EUROPE: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 QUALITY CONTROLS FOR MICROBIOLOGY AVAILABLE IN MARKET
  • TABLE 101 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 EUROPE: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 QUALITY CONTROLS FOR HEMATOLOGY AVAILABLE IN MARKET
  • TABLE 108 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 109 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 EUROPE: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 114 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS AVAILABLE IN MARKET
  • TABLE 115 IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 116 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 EUROPE: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 QUALITY CONTROLS FOR OTHER TECHNOLOGIES AVAILABLE IN MARKET
  • TABLE 122 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 123 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 126 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 KEY THIRD-PARTY CONTROLS AVAILABLE IN MARKET
  • TABLE 130 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 THIRD-PARTY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 133 EUROPE: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 135 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 INDEPENDENT THIRD-PARTY CONTROLS AVAILABLE IN MARKET
  • TABLE 138 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 140 EUROPE: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 142 LATIN AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS AVAILABLE IN MARKET
  • TABLE 145 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 EUROPE: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 151 OEM CONTROLS AVAILABLE IN MARKET
  • TABLE 152 OEM CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 153 NORTH AMERICA: OEM CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 EUROPE: OEM CONTROLS MARKET, 2023-2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: OEM CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: OEM CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 MIDDLE EAST & AFRICA: OEM CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 160 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 161 EUROPE: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 163 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 165 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 166 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 171 IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 EUROPE: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 177 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 183 IVD QUALITY CONTROLS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 185 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 186 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 187 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 189 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 192 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 193 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 195 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 198 US: NUMBER OF IN VITRO DIAGNOSTICS TESTS CONDUCTED, 2022-2030 (BILLION)
  • TABLE 199 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 200 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 202 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 205 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 206 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 207 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 208 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 210 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 213 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 214 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 216 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 219 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 220 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 222 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 225 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 226 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 228 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 231 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 232 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 234 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 237 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 238 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 240 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 243 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 244 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 246 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 249 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 250 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 252 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 256 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 263 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 264 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 266 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 269 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 270 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 272 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 275 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 276 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 278 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 281 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 282 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 284 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 285 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 287 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 288 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 290 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 294 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 296 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 299 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 300 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 301 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 302 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 303 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 304 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 307 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 308 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 310 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 311 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 312 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 313 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 314 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 316 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 317 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 318 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 319 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 320 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 324 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 325 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 326 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 327 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 328 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 330 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 331 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 333 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 334 SAUDI ARABIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 335 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 336 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 337 SAUDI ARABIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 339 UAE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 340 UAE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 341 UAE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 342 UAE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 UAE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 UAE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 345 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 346 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 347 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 348 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 REST OF MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 351 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN IVD QUALITY CONTROLS MARKET, JANUARY 2021-AUGUST 2025
  • TABLE 352 IVD QUALITY CONTROLS MARKET: DEGREE OF COMPETITION
  • TABLE 353 IVD QUALITY CONTROLS MARKET: REGION FOOTPRINT
  • TABLE 354 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE FOOTPRINT
  • TABLE 355 IVD QUALITY CONTROLS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 356 IVD QUALITY CONTROLS MARKET: MANNUFACTURER TYPE FOOTPRINT
  • TABLE 357 IVD QUALITY CONTROLS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 358 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT & SERVICE AND MANUFACTURER TYPE
  • TABLE 359 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 360 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 361 IVD QUALITY CONTROLS MARKET: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 362 IVD QUALITY CONTROLS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 363 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 364 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 365 BIO-RAD LABORATORIES, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 366 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 367 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 368 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 369 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 370 ABBOTT: COMPANY OVERVIEW
  • TABLE 371 ABBOTT: PRODUCTS & SERVICES OFFERED
  • TABLE 372 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 373 LGC LIMITED: PRODUCTS & SERVICES OFFERED
  • TABLE 374 LGC LIMITED: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 375 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 376 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 377 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 378 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
  • TABLE 379 RANDOX LABORATORIES LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 380 RANDOX LABORATORIES LTD.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 381 RANDOX LABORATORIES LTD.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 382 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 383 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
  • TABLE 384 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 385 QUIDELORTHO CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 386 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 387 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 388 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 389 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 390 SYSMEX CORPORATION: COMPANY OVERVIEW
  • TABLE 391 SYSMEX CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 392 SYSMEX CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 393 SYSMEX CORPORATION: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 394 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 395 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
  • TABLE 396 BIO-TECHNE CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 397 BIO-TECHNE CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 398 BIO-TECHNE CORPORATION: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 399 BIO-TECHNE CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 400 MICROBIX BIOSYSTEMS INC.: COMPANY OVERVIEW
  • TABLE 401 MICROBIX BIOSYSTEMS INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 402 MICROBIX BIOSYSTEMS INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 403 MICROBIX BIOSYSTEMS INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 404 GRIFOLS, S.A.: COMPANY OVERVIEW
  • TABLE 405 GRIFOLS, S.A.: PRODUCTS & SERVICES OFFERED
  • TABLE 406 MICROBIOLOGICS, INC.: COMPANY OVERVIEW
  • TABLE 407 MICROBIOLOGICS, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 408 MICROBIOLOGICS, INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 409 ZEPTOMETRIX: COMPANY OVERVIEW
  • TABLE 410 ZEPTOMETRIX: PRODUCTS & SERVICES OFFERED
  • TABLE 411 ZEPTOMETRIX: PRODUCT & SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 412 FORTRESS DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 413 FORTRESS DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
  • TABLE 414 HELENA LABORATORIES CORPORATION: COMPANY OVERVIEW
  • TABLE 415 STRECK, INC.: COMPANY OVERVIEW
  • TABLE 416 MAINE MOLECULAR QUALITY CONTROLS, INC.: COMPANY OVERVIEW
  • TABLE 417 SUN DIAGNOSTICS, LLC: COMPANY OVERVIEW
  • TABLE 418 SERO AS: COMPANY OVERVIEW
  • TABLE 419 CONEBIOPRODUCTS: COMPANY OVERVIEW
  • TABLE 420 ALPHA-TEC: COMPANY OVERVIEW
  • TABLE 421 EUROTROL B.V.: COMPANY OVERVIEW
  • TABLE 422 BIOREX DIAGNOSTICS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 IVD QUALITY CONTROLS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 IVD QUALITY CONTROLS MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 8 IVD QUALITY CONTROLS MARKET: TOP-DOWN APPROACH
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 IVD QUALITY CONTROLS MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 IVD QUALITY CONTROLS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET
  • FIGURE 17 QUALITY CONTROL PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 IMMUNOASSAYS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 19 THIRD-PARTY CONTROLS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 20 HOSPITALS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030
  • FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
  • FIGURE 22 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NUMBER OF CLIA-ACCREDITED LABORATORIES, BY ACCREDITATION ORGANIZATION (2024)
  • FIGURE 24 PATENT ANALYSIS FOR QUALITY CONTROLS FOR DIAGNOSTICS, JANUARY 2015-DECEMBER 2024
  • FIGURE 25 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 IVD QUALITY CONTROLS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 IVD QUALITY CONTROLS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 29 IVD QUALITY CONTROLS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE
  • FIGURE 31 KEY BUYING CRITERIA, BY PRODUCT & SERVICE
  • FIGURE 32 NUMBER OF DEALS & FUNDING ACTIVITIES IN IVD QUALITY CONTROLS MARKET
  • FIGURE 33 MARKET POTENTIAL OF AI IN IVD QUALITY CONTROLS MARKET
  • FIGURE 34 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET (2022-2024)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET (2024)
  • FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 39 IVD QUALITY CONTROLS MARKET: COMPANY FOOTPRINT
  • FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 IVD QUALITY CONTROLS MARKET: BRAND COMPARISON
  • FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2024)
  • FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 50 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 53 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 MICROBIX BIOSYSTEMS INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!